nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.757	1	CbGbCtD
Nitric Oxide—Methaemoglobinaemia—Riluzole—amyotrophic lateral sclerosis	0.0412	0.285	CcSEcCtD
Nitric Oxide—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.0244	0.168	CcSEcCtD
Nitric Oxide—GUCY1B3—tongue—amyotrophic lateral sclerosis	0.0131	0.147	CbGeAlD
Nitric Oxide—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0088	0.0608	CcSEcCtD
Nitric Oxide—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0428	CcSEcCtD
Nitric Oxide—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00612	0.0423	CcSEcCtD
Nitric Oxide—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00609	0.042	CcSEcCtD
Nitric Oxide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00565	0.039	CcSEcCtD
Nitric Oxide—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00552	0.0382	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00549	0.0379	CcSEcCtD
Nitric Oxide—GUCY1A2—nervous system—amyotrophic lateral sclerosis	0.00481	0.0542	CbGeAlD
Nitric Oxide—GUCY1A2—central nervous system—amyotrophic lateral sclerosis	0.00463	0.0522	CbGeAlD
Nitric Oxide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00459	0.0317	CcSEcCtD
Nitric Oxide—GUCY1A2—cerebellum—amyotrophic lateral sclerosis	0.00452	0.0511	CbGeAlD
Nitric Oxide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00451	0.0312	CcSEcCtD
Nitric Oxide—Shock—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0294	CcSEcCtD
Nitric Oxide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00424	0.0293	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00423	0.0292	CcSEcCtD
Nitric Oxide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00404	0.0279	CcSEcCtD
Nitric Oxide—GUCY1A3—medulla oblongata—amyotrophic lateral sclerosis	0.00403	0.0455	CbGeAlD
Nitric Oxide—GUCY1B3—medulla oblongata—amyotrophic lateral sclerosis	0.004	0.0451	CbGeAlD
Nitric Oxide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0266	CcSEcCtD
Nitric Oxide—GUCY1A2—brain—amyotrophic lateral sclerosis	0.00367	0.0415	CbGeAlD
Nitric Oxide—GUCY1A3—spinal cord—amyotrophic lateral sclerosis	0.00359	0.0406	CbGeAlD
Nitric Oxide—GUCY1B3—spinal cord—amyotrophic lateral sclerosis	0.00357	0.0403	CbGeAlD
Nitric Oxide—ALDH2—medulla oblongata—amyotrophic lateral sclerosis	0.0034	0.0383	CbGeAlD
Nitric Oxide—ALDH2—spinal cord—amyotrophic lateral sclerosis	0.00303	0.0342	CbGeAlD
Nitric Oxide—GUCY1A3—nervous system—amyotrophic lateral sclerosis	0.00303	0.0342	CbGeAlD
Nitric Oxide—GUCY1B3—nervous system—amyotrophic lateral sclerosis	0.00301	0.0339	CbGeAlD
Nitric Oxide—GUCY1A3—central nervous system—amyotrophic lateral sclerosis	0.00292	0.0329	CbGeAlD
Nitric Oxide—GUCY1B3—central nervous system—amyotrophic lateral sclerosis	0.00289	0.0327	CbGeAlD
Nitric Oxide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0198	CcSEcCtD
Nitric Oxide—GUCY1A3—cerebellum—amyotrophic lateral sclerosis	0.00285	0.0322	CbGeAlD
Nitric Oxide—GUCY1B3—cerebellum—amyotrophic lateral sclerosis	0.00283	0.0319	CbGeAlD
Nitric Oxide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0187	CcSEcCtD
Nitric Oxide—ALDH2—nervous system—amyotrophic lateral sclerosis	0.00255	0.0288	CbGeAlD
Nitric Oxide—ALDH2—central nervous system—amyotrophic lateral sclerosis	0.00246	0.0277	CbGeAlD
Nitric Oxide—ALDH2—cerebellum—amyotrophic lateral sclerosis	0.0024	0.0271	CbGeAlD
Nitric Oxide—GUCY1A3—brain—amyotrophic lateral sclerosis	0.00231	0.0261	CbGeAlD
Nitric Oxide—GUCY1B3—brain—amyotrophic lateral sclerosis	0.0023	0.0259	CbGeAlD
Nitric Oxide—ALDH2—brain—amyotrophic lateral sclerosis	0.00195	0.022	CbGeAlD
Nitric Oxide—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.00115	0.0129	CbGeAlD
Nitric Oxide—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.0011	0.0124	CbGeAlD
Nitric Oxide—CYP2B6—brain—amyotrophic lateral sclerosis	0.000875	0.00988	CbGeAlD
Nitric Oxide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000865	0.00976	CbGeAlD
Nitric Oxide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000833	0.0094	CbGeAlD
Nitric Oxide—GUCY1A2—Platelet homeostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00032	0.0351	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Platelet homeostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00032	0.0351	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Platelet homeostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000286	0.0313	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000265	0.0291	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000265	0.0291	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IGFBP3—amyotrophic lateral sclerosis	0.000265	0.0291	CbGpPWpGaD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000243	0.0267	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000236	0.0259	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000231	0.0254	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ATF1—amyotrophic lateral sclerosis	0.000215	0.0236	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000214	0.0234	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000206	0.0226	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000199	0.0219	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000189	0.0207	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000184	0.0202	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000184	0.0202	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000177	0.0195	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000175	0.0192	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000175	0.0192	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000171	0.0187	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000171	0.0187	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000166	0.0182	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000166	0.0182	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000164	0.018	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000164	0.018	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000158	0.0173	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000156	0.0171	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000152	0.0167	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000148	0.0162	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000145	0.0159	CbGpPWpGaD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000143	0.0157	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000134	0.0147	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000134	0.0147	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00012	0.0131	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00011	0.0121	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000106	0.0117	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—VAPB—amyotrophic lateral sclerosis	8.15e-05	0.00894	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—TPK1—amyotrophic lateral sclerosis	8.15e-05	0.00894	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SOD1—amyotrophic lateral sclerosis	8e-05	0.00878	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SOD1—amyotrophic lateral sclerosis	8e-05	0.00878	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—VAPA—amyotrophic lateral sclerosis	7.45e-05	0.00818	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	7.18e-05	0.00787	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	7.18e-05	0.00787	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—SOD1—amyotrophic lateral sclerosis	7.13e-05	0.00782	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.93e-05	0.0076	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—FIG4—amyotrophic lateral sclerosis	6.52e-05	0.00715	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	6.4e-05	0.00702	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.31e-05	0.00692	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—DAO—amyotrophic lateral sclerosis	5.89e-05	0.00646	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	5.22e-05	0.00573	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.88e-05	0.00535	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.88e-05	0.00535	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.47e-05	0.0049	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.35e-05	0.00477	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSR—amyotrophic lateral sclerosis	4.12e-05	0.00452	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.11e-05	0.0045	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.72e-05	0.00408	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.38e-05	0.00371	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.19e-05	0.0035	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.19e-05	0.0035	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.87e-05	0.00315	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	2.86e-05	0.00314	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	2.84e-05	0.00312	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.84e-05	0.00312	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.82e-05	0.0031	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.79e-05	0.00305	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.62e-05	0.00287	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	2.47e-05	0.00271	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.43e-05	0.00267	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TP53—amyotrophic lateral sclerosis	2.41e-05	0.00264	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TP53—amyotrophic lateral sclerosis	2.41e-05	0.00264	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.31e-05	0.00254	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.29e-05	0.00251	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.16e-05	0.00237	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.16e-05	0.00237	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TP53—amyotrophic lateral sclerosis	2.15e-05	0.00235	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.98e-05	0.00217	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	1.95e-05	0.00214	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.84e-05	0.00202	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.82e-05	0.002	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.73e-05	0.0019	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.67e-05	0.00183	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.66e-05	0.00182	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.64e-05	0.0018	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.57e-05	0.00172	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	1.56e-05	0.00172	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—APOE—amyotrophic lateral sclerosis	1.38e-05	0.00151	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.28e-05	0.00141	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.27e-05	0.0014	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.27e-05	0.0014	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.27e-05	0.00139	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.19e-05	0.0013	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.19e-05	0.0013	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.17e-05	0.00128	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.09e-05	0.0012	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.08e-05	0.00119	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.02e-05	0.00112	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	9.83e-06	0.00108	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	9.83e-06	0.00108	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.42e-06	0.00103	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	9.21e-06	0.00101	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.99e-06	0.000986	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.99e-06	0.000986	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.36e-06	0.000917	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.86e-06	0.000862	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.11e-06	0.00078	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.98e-06	0.000766	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	6.44e-06	0.000707	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.87e-06	0.000644	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.39e-06	0.000591	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	5.29e-06	0.00058	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.97e-06	0.000545	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.83e-06	0.00053	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.83e-06	0.00053	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.44e-06	0.000487	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.08e-06	0.000448	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	3.65e-06	0.000401	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.31e-06	0.000363	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.84e-06	0.000312	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.61e-06	0.000287	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.5e-06	0.000274	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.19e-06	0.000241	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.15e-06	0.000236	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.02e-06	0.000221	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.66e-06	0.000182	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.47e-06	0.000162	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.14e-06	0.000125	CbGpPWpGaD
